Ligand id: 7465

Name: dronedarone

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: dronedarone

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 18
Topological polar surface area 97.23
Molecular weight 556.3
XLogP 7.46
No. Lipinski's rules broken 2

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Approved to treat life-threatening atrial flutter and fibrilation by restoring synus rhythm.
Mechanism Of Action and Pharmacodynamic Effects
Dronedarone's mechanism of action is complex, with clinical efficacy arising from actions as a multi-channel blocker, affecting potassium, sodium and calcium currents, as well as antagonism of α- and β-adrenoceptors. Inhibition of sodium and potassium currents appears to prolong the duration of action potential and refractory period in myocardial tissue. Additionally, inhibition of calcium channels and antagonism of β1-adrenoceptors may decrease the abnormal AV conduction and sinus node function associated with atrial fibrillation. Studies in pigs suggest that inhibition of the sinoatrial node If current via HCN channels is the principal mechanism underlying dronedarone's bradycardic action [4]. Dronedarone's antifibrillatory action may also be attributed, in part, to inhibition of inward-rectifier potassium channels, especially Kir2.1 [3,6].
External links